Transasia Bio-Medicals Ltd. announces partnership with Immco Diagnostics,
USA for Autoimmune Diagnosis.
Immco Diagnostics Inc. is dedicated to the field of Autoimmune since 1971. The company’s devoted research team, works closely with the industry experts to develop proprietary products which has led to innovations such as, first to develop the commercial assay for Endomysial antibodies, 1st panel for autoimmune hearing loss diagnosis i.e. Oto blot
The company offers leading autoimmune disease diagnostic assays under the ImmuGlo™ (immunofluoresence assay), ImmuLisa™ (enzyme linked immunosorbent assay), and ImmuBlot™ (Western blot assay) brands.
|
![]() |
![]() |
|
![]() |
![]() |
ImmuLisa™ |
ImmuGlo™ |
ImmuBlot™ |
ImmuLisa™: The NEW ImmuLisa™ enhanced assays feature cutting edge technologic advantages:
Immco ImmuLisa™ ELISA enhanced assays are developed with the laboratory’s needs in mind. Efficiency, ease of use and objective, quantifiable results characterize these newly enhanced kits, establishing them as the new industry standard in ELISA technology.
ImmuBlot™: Current Product Range for Autoimmune covers:
For more information visit : www.immco.com |
||